Csenge Advisory Group’s Bausch Health BHC Stock Holding History

Csenge Advisory Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30	Closed	–	–	337
2018 Q3	$0	Buy	+30	New	+$687	﹤0.01%	1077

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Csenge Advisory Group's BHC Position: Q4 2018 in Review

Csenge Advisory Group sold out of Bausch Health (BHC) in Q4 2018, closing a stake of 30 shares.

Csenge Advisory Group first reported a position in BHC in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 334 funds tracked by Wall St. Rank hold BHC as of Q4 2018.

Csenge Advisory Group reported no remaining Bausch Health position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 30 Bausch Health shares in Q4 2018.
Csenge Advisory Group first reported a position in Bausch Health in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Bausch Health position peaked at $0 in Q3 2018.
334 funds tracked by Wall St. Rank held Bausch Health as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.